Risultati di ricerca
4 giorni fa · RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology.
4 giorni fa · What is RAPT Therapeutics's stock forecast and purchase recommendation? According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for RAPT Therapeutics is $24.67, with a high forecast of $41.00 and a low forecast of $4.00.
- 561 ECCLES AVENUE, SOUTH SAN FRANCISCO CA, 94080
- investors@rapt.com
- (844) 978-6257
- 131
2 giorni fa · Should You Buy or Sell RAPT Therapeutics Stock? Get The Latest RAPT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (650) 489-9000
- 561 ECCLES AVENUE, SOUTH SAN FRANCISCO CA, 94080
- investors@rapt.com
4 giorni fa · Rapt Therapeutics (RAPT) has been beaten down lately with too much selling pressure. While the stock has lost 47.1% over the past four weeks, there is light at the end of the tunnel as it is...
3 giorni fa · Which shareholders are buying/selling shares of RAPT Therapeutics (NASDAQ:RAPT) stock? View RAPT institutional ownership (13F) transactions at MarketBeat.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
4 giorni fa · Billion Dollar Secret. View Rapt Therapeutics RAPT investment & stock information. Get the latest Rapt Therapeutics RAPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and...
1 giorno fa · A. RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ. RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research,...
